Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a

Status Completed

Clinical Trial Summary

Cerebral glycolytic metabolism can be quantified by quantitative analysis of 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET). This allows to identify neurological diseases at an early stage of functional abnormalities, before any anatomical lesions, and to differentiate them from the "normal" brain aging. Aging mainly leads to atrophy with a decrease in cerebral metabolism in the prefrontal cortex, with consequent deterioration of cognitive processes, in particular executive functions (5). In a population of 92 "control" subjects, investigators have already quantified the importance of the aging in frontal cortex hypometabolism. These patients were referred for a 18F-FDG PET in the follow-up of lymphoma considered to be in complete remission (PET without cerebral step), without any chemoradiotherapy within 2 months and with normal neuropsychological tests (Mini Mental State Examination, MMSE, Mini International Neuropsychiatric Interview MINI and Frontal Assessment Battery FAB). However, cerebral aging can be "accelerated" by vascular risk factors, including increased central blood pressure, as investigators have recently reported in a pilot study involving elderly patients. This central pressure, which is directly linked to the cerebral micro-vascularization, can be easily measured by applanation tonometry. In this pilot study, investigators showed that a central pulse pressure equal or greater than 50 mmHg was associated with a significant frontal hypometabolism in elderly patients. This confirmed, at a stage of pre-clinical remodeling, the worse prognostic significance for this criterion, as reported in large epidemiological studies (increased risk of stroke and cardiac vascular events). However, it is not yet known whether the level of central blood pressure interfere with the brain metabolism of younger subjects, especially with regard to aging observed throughout life. If this hypothesis is confirmed, preventive therapeutic strategies for accelerated aging, could thus integrate the monitoring of central pressure and cerebral metabolism. The objective of this study is to determine, in a population of control subjects and on a larger scale, the impact of central blood pressure on brain metabolic aging , by using 18F-FDG PET.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Aging Disorder

Clinical Trial Details

NCT number	NCT03345290
Study type	Interventional
Source	Central Hospital, Nancy, France
Contact
Status	Completed
Phase	N/A
Start date	July 31, 2018
Completion date	November 6, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05961319` - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Recruiting	`NCT04518423` - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
Completed	`NCT04321187` - Influence of Prostate Cancer Radiation on Aging
Recruiting	`NCT04301713` - Multifactorial Study of the Relationship Between the Conditions of Life and the Incidence of Risk of Falling
Completed	`NCT03704090` - Non-pharmacological Prevention of Postoperative Delirium by Occupational Therapy Teams	N/A
Active, not recruiting	`NCT05046275` - MCR Syndrome in Quebec : Results From NuAge Study
Recruiting	`NCT04669782` - Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging	N/A
Completed	`NCT06255431` - EFFECTIVENESS AND SAFETY OF CREAM CONTAINING SPENT GRAIN WAX EXTRACT, ARGAN OIL, AND SHEA BUTTER POST-TRICHOLOROACETIC ACID 15% PEEL: RANDOMIZED, CONTROLLED, DOUBLE-BLIND, SPLIT-FACE CLINICAL TRIAL	Phase 4
Not yet recruiting	`NCT06267625` - Physical Impairments in Elderly Individuals
Not yet recruiting	`NCT05085535` - Study of Manual Therapy Plus Therapeutic Exercise in Geriatrics	N/A
Enrolling by invitation	`NCT03320005` - EFFECTS OF RESISTANCE TRAINING IN ELDERLY	N/A
Recruiting	`NCT04026815` - Health Status and Its Socio-economic Covariates of the Older Population in Poland - the Nationwide PolSenior2 Survey.
Recruiting	`NCT03702907` - DC Longitudinal Study on Aging and Specimen Bank
Recruiting	`NCT06268132` - Longevity in Russia
Recruiting	`NCT05552677` - Effects of Multicomponent Training on Inflammation Parameters and Muscle Quality in Elderly Obese Woman	N/A
Not yet recruiting	`NCT03848897` - Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients	N/A
Completed	`NCT04151654` - Effects of Footwear Suitability on Functional Performance and Balance in Elderly	N/A
Recruiting	`NCT04221282` - ZEBinix® Retention Rate in Epilepsy in Elderly Patients
Recruiting	`NCT04169633` - Spanish Adaptation and Validation of the Everyday Cognition Battery (ECB).

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study. — PACTEP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms